Caris Life Sciences, Inc. (CAI) Stock

Caris Life Sciences, Inc. (CAI) is a Healthcare stock trading at $18.48 (as of 2026-06-18), with a market capitalization of $4.73B and a trailing P/E of 51.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Valuation — source: SEC EDGAR (first-party)
Price$18.48
Market Cap$4.73B
P/E Ratio51.3
EV / EBITDA36.0
Price / Book8.56
Price / Sales5.60
DCF Value (model)$5.52
DCF Upside vs Price-70.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$812.03M
Net Margin-8.4%
Return on Equity5.7%
Debt / Equity0.64
Current Ratio7.05
Revenue Growth (YoY)78.8%
EPS Growth (YoY)-100.0%
FCF Growth (YoY)-166.2%
Financial Health — source: SEC EDGAR
Altman Z-Score4.32 (safe)
Valuation vs Sector & Industry
Stock P/E51.3
Sector P/E (Healthcare)21.0
Industry P/E (Healthcare Services)23.0
vs Sector145.0%
vs Industry122.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($550.45M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryHealthcare Services
CEODavid Dean Halbert
Employees1,769
CountryUS
IPO Date2025-06-18

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Medpace Holdings, Inc. (MEDP)
  • ICON Public Limited Company (ICLR)
  • Guardant Health, Inc. (GH)
  • Charles River Laboratories International, Inc. (CRL)
  • Repligen Corporation (RGEN)
  • RadNet, Inc. (RDNT)
  • Celcuity Inc. (CELC)
  • GRAIL, Inc. (GRAL)
CAI earnings history · CAI institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.